The pathways involving EGFR signaling (51.2%), p53 signaling (48.8%), PI3K (39.5%), and RTKs (34.9%) were found to be frequently involved, suggesting that they may contribute to the tumorigenesis and progression of tonsil cancer [11,27,33,34,35,36,37]. Here, EGFR is linked to tonsil cancer.